NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces it has appointed CordenPharma as its manufacturing partner. The opening of a new manufacturing line and the scaling up of production is an important step in NBTXR3s route to commercialization.
The new manufacturing line, located in France, will increase the amount of NBTXR3 product available. With an anticipated award of a CE mark in 2016, the Company is preparing to scale-up production further to meet the needs of future commercialization. Furthermore, Nanobiotix is anticipating future demand from clinical trials in the coming years in Europe and in the United States.
CordenPharma is an international full service CMO (contract manufacturing organization) which provides specialized technologies for the development and manufacture of health products. The company is recognized by EMA and FDA thanks to its eight cGMP facilities across Europe and the United States and works with both pharma and biotech companies. Its facilities are regularly inspected by the regulatory authorities (FDA and EMA) and have a good track record.
Laurent Lvy, Chief Executive Officer at Nanobiotix, commented: Finding the right manufacturing partner is essential, since ensuring quality and sufficient levels of supply is fundamental for meeting the market demands and the growth of the Company.
Yves Michon, Prsident Synkem - CordenPharma said: Nanobiotixs product, NBTXR3 is a fascinating product not only with respect to its properties, but also in its manufacture. We are working closely with Nanobiotix to ensure a seamless process and manage the scale-up of the product.
NBTXR3 is Nanobiotixs lead product in the NanoXray portfolio. The product comprises Hafnium Oxide nanoparticles which can be injected directly into tumor. With the application of radiotherapy, these nanoparticles absorb X-rays have the potential to significantly enhances the radiation dose within the cancer cells without increasing the dose to the surrounding healthy tissues. NBTXR3 has the potential to cause a paradigm shift in cancer therapy with significant clinical benefit for patients.
In November 2014, Nanobiotix announced its global clinical development plan. In addition to Soft Tissue Sarcoma and Head and Neck cancer, the plan now includes metastatic liver cancer, hepatocellular carcinomas and prostate cancer. In the second half of 2015, the liver cancers and high risk prostate cancer programs are anticipated to enter the clinical stage.
About NANOBIOTIX: http://www.nanobiotix.com
Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer. The companys first-in-class, proprietary technology, NanoXray, enhances radiotherapy energy with a view to provide a new, more efficient treatment for cancer patients. NanoXray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of cancers including Soft Tissue Sarcoma, Head and Neck Cancer, Liver Cancers, Prostate Cancer, Breast Cancer, Glioblastoma, etc., via multiple routes of administration.
Nanobiotixs lead product NBTXR3, based on NanoXray, is currently under clinical development for Soft Tissue Sarcoma and locally advanced Head and Neck Cancer. The company has partnered with PharmaEngine for clinical development and commercialization of NBTXR3 in Asia.
See the rest here:
Nanobiotix Appoints Its Manufacturing Partner, CordenPharma: Another Step Towards Commercialization
- Advances in nanotechnology's fight against cancer - December 27th, 2013 [December 27th, 2013]
- Nanotechnology and Medicine - Nanomedicine and Disease ... - December 27th, 2013 [December 27th, 2013]
- Nanomedicine: Nanotechnology, Biology and Medicine - Official Site - December 27th, 2013 [December 27th, 2013]
- Nanomedicine Fact Sheet - December 27th, 2013 [December 27th, 2013]
- Nanomedicine, bionanotechnology | NanomedicineCenter.com - December 27th, 2013 [December 27th, 2013]
- Nanomedicine - Wikipedia, the free encyclopedia - December 27th, 2013 [December 27th, 2013]
- Nanomedicine for drug delivery - Srinivas Sridhar - Video - December 28th, 2013 [December 28th, 2013]
- IT-CRS 2013 workshop- Prof. Kevin Breackmans. Studying nanomedicine biobarriers - Video - December 30th, 2013 [December 30th, 2013]
- Nanotechnology in Medicine - UnderstandingNano - January 3rd, 2014 [January 3rd, 2014]
- Nanomedicine - Nanorobots in Medicine - UnderstandingNano - January 8th, 2014 [January 8th, 2014]
- Nanomedicine: Challenges and opportunities - Video - January 13th, 2014 [January 13th, 2014]
- Global Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019: Transparency Market Research - January 16th, 2014 [January 16th, 2014]
- NANOMEDICINE 1 - Video - January 17th, 2014 [January 17th, 2014]
- Researchers measure minuscule particles with 'tiny diving boards' - January 20th, 2014 [January 20th, 2014]
- High Unmet Needs in Therapeutics to Spur Growth in the Market for Nanotechnology in Drug Delivery, According to New ... - January 21st, 2014 [January 21st, 2014]
- Nanomedicine Market - Video - January 22nd, 2014 [January 22nd, 2014]
- Nanomedicine and human upper limit - Video - January 23rd, 2014 [January 23rd, 2014]
- Animated Nanomedicine movie - Video - February 2nd, 2014 [February 2nd, 2014]
- In Vitro Innovation: Testing Nanomedicine With Blood Cells On A Microchip - February 4th, 2014 [February 4th, 2014]
- Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019 - February 7th, 2014 [February 7th, 2014]
- NANOMEDICINE 4: AYDEN JACOB FROM UCSF - Video - February 7th, 2014 [February 7th, 2014]
- New Live-Cell Printing Technology Works Like Ancient Chinese Woodblocking - February 10th, 2014 [February 10th, 2014]
- NANOMEDICINE HANGOUT: ARSALAN SHABBIR MD - Video - February 14th, 2014 [February 14th, 2014]
- Using Mathematical Models to Understand Nanoscale Roughness Published by Dove Medical Press - February 17th, 2014 [February 17th, 2014]
- NTU and Northwestern University to set up $70 million nanomedicine research institute - February 20th, 2014 [February 20th, 2014]
- Interview with Medical Animator YURIY SVIDINENKO, about Nanotechnology Videos - Video - February 21st, 2014 [February 21st, 2014]
- TTU MSE nanomedicine lab NML 2013 f - Video - February 21st, 2014 [February 21st, 2014]
- Nanomedicine Vietsubtitles - Video - February 24th, 2014 [February 24th, 2014]
- Biochips for Better Cancer Therapy in NanoMedicine - Video - February 27th, 2014 [February 27th, 2014]
- 13 Nanomedicine Part 1 - Video - February 28th, 2014 [February 28th, 2014]
- 13 Nanomedicine part 2 - Video - February 28th, 2014 [February 28th, 2014]
- practicum nanomedicine pws Nicole en jordy - Video - March 6th, 2014 [March 6th, 2014]
- Nanomedicine, Detto tra Noi, 4 marzo 2014 - Video - March 6th, 2014 [March 6th, 2014]
- Brown Symposium XXXVI - Mauro Ferrari: "Nanomedicine and New Societal Horizons" - Video - March 9th, 2014 [March 9th, 2014]
- nanomedicine nanobiotix itele - Video - March 9th, 2014 [March 9th, 2014]
- NANOMEDICINE HANGOUT UNIVERSITY OF MIAMI ARSALAN SHABBIR MD - Video - March 16th, 2014 [March 16th, 2014]
- NANOMEDICINE HANGOUT1 - Video - March 21st, 2014 [March 21st, 2014]
- NANOMEDICINE HANGOUT - Video - March 21st, 2014 [March 21st, 2014]
- Ideas @Davos | Sonia Trigueros | Breakthroughs in Nanomedicine - Video - March 22nd, 2014 [March 22nd, 2014]
- Nanomedicine: towards development of patient-friendly drug-delivery systems - Video - March 23rd, 2014 [March 23rd, 2014]
- Nanomedicine Research - March 26th, 2014 [March 26th, 2014]
- Mining Genome Information for New Starting Points in Personalized Cancer Nanomedicine - Video - March 28th, 2014 [March 28th, 2014]
- Cancer Stem Cells as Preferential Target for Personalized Cancer Nanomedicine - Video - March 28th, 2014 [March 28th, 2014]
- Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium - Video - March 29th, 2014 [March 29th, 2014]
- Panel - The Horizon of Nanomedicine and Targeted Drug Delivery - Video - March 29th, 2014 [March 29th, 2014]
- Panel - The Regulation Environment in Nanomedicine -- The Step to the Last Phase of Translation - Video - March 29th, 2014 [March 29th, 2014]
- Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics - Video - March 29th, 2014 [March 29th, 2014]
- Nanobiotix Selected to Present Data from NBTXR3 Clinical Trial at the 50th Annual Meeting of the American Society of ... - April 2nd, 2014 [April 2nd, 2014]
- Breakthroughs in Nanomedicine-A World Economic Forum Discussion-Ideas @Davos-WIRED - Video - April 4th, 2014 [April 4th, 2014]
- How IBM Is Using Nanotechnology To Tackle MRSA And HIV - April 5th, 2014 [April 5th, 2014]
- In latest generation of tiny biosensors, size isn't everything - April 14th, 2014 [April 14th, 2014]
- Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global ... - April 17th, 2014 [April 17th, 2014]
- doctors-hospital-surgery-AFprelax-210414.jpg - April 21st, 2014 [April 21st, 2014]
- Nanomedicine - Video - April 25th, 2014 [April 25th, 2014]
- Nanomedicine Presentation - Video - May 6th, 2014 [May 6th, 2014]
- Nanomedicine Promo - Video - May 6th, 2014 [May 6th, 2014]
- A skinful of nanoparticles starts to show - May 16th, 2014 [May 16th, 2014]
- nanomedicine edit1 - Video - May 17th, 2014 [May 17th, 2014]
- UB spinoff Nanobiotix working to bring cancer treatment to market - May 29th, 2014 [May 29th, 2014]
- DGAP-News: MagForce AG: MagForce AG to present at dbAccess German, Swiss & Austrian Conference 2014, held by Deutsche ... - June 2nd, 2014 [June 2nd, 2014]
- New nanomedicine by NTU and SERI scientists to bring relief to glaucoma patients - June 4th, 2014 [June 4th, 2014]
- New glaucoma treatment replaces the hassle of applying eyedrops daily - June 4th, 2014 [June 4th, 2014]
- Cancer Nanomedicine - The Cancer Nanomedicine Blog - June 5th, 2014 [June 5th, 2014]
- No More Eye Drops for Glaucoma - June 10th, 2014 [June 10th, 2014]
- Nanomatriaux 2014 - AGuIX in nanomedicine - Video - June 19th, 2014 [June 19th, 2014]
- Introduction to nanomedicine with emphasis on carrier-mediated drug targeting - Video - June 20th, 2014 [June 20th, 2014]
- Challenging the Old Order to Set New Frontiers in Nanoscience & Nanotechnology - June 21st, 2014 [June 21st, 2014]
- Welcome - Summer School on Nanomedicine and Innovation - Video - June 24th, 2014 [June 24th, 2014]
- Nanomedicine and IP - Video - June 25th, 2014 [June 25th, 2014]
- Global Nanomedicine Market: Industry Analysis, Size, Share,Growth, Trends, and Forecast 2013 - 2019 - June 30th, 2014 [June 30th, 2014]
- Scientists engineer nanoparticles to prevent bone cancer, strengthen bones - July 2nd, 2014 [July 2nd, 2014]
- Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019 - July 4th, 2014 [July 4th, 2014]
- Nanobiotix revenue for the 2nd quarter of 2014 - July 11th, 2014 [July 11th, 2014]
- magforce - Using advanced nanomedicine for innovative therapies - Video - July 25th, 2014 [July 25th, 2014]
- Shelton firms products in the pipeline could end diseases - July 29th, 2014 [July 29th, 2014]
- In the Quest to Treat Intracerebral Hemorrhage, Nanomaterials Show Promise - July 31st, 2014 [July 31st, 2014]
- Researchers to track effects of revolutionary new medicines - August 8th, 2014 [August 8th, 2014]
- Nanomedicine & RA with Dr. Bottini - Video - August 8th, 2014 [August 8th, 2014]
- Cellular Surgeons: The New Era of Nanomedicine - Full Program - Video - August 8th, 2014 [August 8th, 2014]
- DGAP-News: MagForce AG: Successful final closing of a growth financing round for MagForce USA, Inc. under the lead of ... - August 9th, 2014 [August 9th, 2014]